Craig J W, Larner J, Locker E F, Elders M J
Mol Cell Biochem. 1985 Mar;66(2):117-25. doi: 10.1007/BF00220779.
Post-receptor or post-binding events in the action of insulin have been investigated in cultured skin fibroblasts from an infant with leprechaunism. Both diminished binding of insulin and multiplication-stimulating activity (MSA) to these cells as well as deficits distal to binding were described in a previous publication. Exposure of control fibroblasts to low concentrations (0.001 to 0.01%) of trypsin for one min without glucose in the medium activated the enzyme glycogen synthase; activation was less than that observed with a maximally effective concentration (10(-6) M) of insulin alone. In cells from the patient with leprechaunism, the effect of trypsin was much smaller than in the control fibroblasts. Exposing the control cells to soybean trypsin inhibitor before addition of trypsin prevented activation of glycogen synthase and demonstrated the specificity of the proteolytic action of trypsin. The rates of activation and inactivation of glycogen synthase in vitro were similar in extracts of the control subject's and the patient's fibroblasts and indicated that the enzymes regulating the phosphorylation/dephosphorylation of glycogen synthase were intact in the patient's cells. Total glycogen synthase activity and glycogen content were also indistinguishable in control and leprechaun fibroblasts. These results are compatible with the presence of an abnormality in the structure or availability of the protease substrate from which chemical mediators of insulin action are formed in the patient's cells. Two possible models for a receptor-coupling complex are proposed. Either a mutation in a regulator-substrate unit of the receptor-coupling complexes for insulin and certain insulin-like growth factors or an alteration in the environment of the unit are postulated to explain the findings.
对一名患脂肪代谢障碍侏儒症婴儿的培养皮肤成纤维细胞中胰岛素作用的受体后或结合后事件进行了研究。先前的一篇报道描述了胰岛素与这些细胞的结合减少以及增殖刺激活性(MSA)降低,同时还存在结合后的缺陷。在无葡萄糖的培养基中,将对照成纤维细胞暴露于低浓度(0.001%至0.01%)的胰蛋白酶中1分钟,可激活糖原合酶;其激活程度低于单独使用最大有效浓度(10⁻⁶ M)胰岛素时观察到的激活程度。在患脂肪代谢障碍侏儒症患者的细胞中,胰蛋白酶的作用比对照成纤维细胞小得多。在添加胰蛋白酶之前,将对照细胞暴露于大豆胰蛋白酶抑制剂中可防止糖原合酶的激活,并证明了胰蛋白酶蛋白水解作用的特异性。对照受试者和患者成纤维细胞提取物中糖原合酶体外激活和失活的速率相似,这表明调节糖原合酶磷酸化/去磷酸化的酶在患者细胞中是完整的。对照和脂肪代谢障碍侏儒症成纤维细胞中的总糖原合酶活性和糖原含量也没有差异。这些结果与患者细胞中形成胰岛素作用化学介质的蛋白酶底物的结构或可用性异常的存在相一致。提出了两种受体偶联复合物的可能模型。推测胰岛素和某些胰岛素样生长因子的受体偶联复合物的调节 - 底物单元发生突变,或者该单元的环境发生改变,以解释这些发现。